Global Urological Cancer Drugs Market Growth (Status and Outlook) 2024-2031

Report ID: 1394961 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Urological Cancer Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Urological Cancer Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Urological Cancer Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Urological Cancer Drugs Segment by Type
        2.2.1 Tablets
        2.2.2 Injection
    2.3 Urological Cancer Drugs Sales by Type
        2.3.1 Global Urological Cancer Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Urological Cancer Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Urological Cancer Drugs Sale Price by Type (2017-2022)
    2.4 Urological Cancer Drugs Segment by Application
        2.4.1 Prostate Cancer
        2.4.2 Bladder Cancer
        2.4.3 Kidney Cancer
        2.4.4 Testicular Cancer
        2.4.5 Others
    2.5 Urological Cancer Drugs Sales by Application
        2.5.1 Global Urological Cancer Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Urological Cancer Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Urological Cancer Drugs Sale Price by Application (2017-2022)
3 Global Urological Cancer Drugs by Company
    3.1 Global Urological Cancer Drugs Breakdown Data by Company
        3.1.1 Global Urological Cancer Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Urological Cancer Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Urological Cancer Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Urological Cancer Drugs Revenue by Company (2020-2022)
        3.2.2 Global Urological Cancer Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Urological Cancer Drugs Sale Price by Company
    3.4 Key Manufacturers Urological Cancer Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Urological Cancer Drugs Product Location Distribution
        3.4.2 Players Urological Cancer Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Urological Cancer Drugs by Geographic Region
    4.1 World Historic Urological Cancer Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Urological Cancer Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Urological Cancer Drugs Annual Revenue by Geographic Region
    4.2 World Historic Urological Cancer Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Urological Cancer Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Urological Cancer Drugs Annual Revenue by Country/Region
    4.3 Americas Urological Cancer Drugs Sales Growth
    4.4 APAC Urological Cancer Drugs Sales Growth
    4.5 Europe Urological Cancer Drugs Sales Growth
    4.6 Middle East & Africa Urological Cancer Drugs Sales Growth
5 Americas
    5.1 Americas Urological Cancer Drugs Sales by Country
        5.1.1 Americas Urological Cancer Drugs Sales by Country (2017-2022)
        5.1.2 Americas Urological Cancer Drugs Revenue by Country (2017-2022)
    5.2 Americas Urological Cancer Drugs Sales by Type
    5.3 Americas Urological Cancer Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Urological Cancer Drugs Sales by Region
        6.1.1 APAC Urological Cancer Drugs Sales by Region (2017-2022)
        6.1.2 APAC Urological Cancer Drugs Revenue by Region (2017-2022)
    6.2 APAC Urological Cancer Drugs Sales by Type
    6.3 APAC Urological Cancer Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Urological Cancer Drugs by Country
        7.1.1 Europe Urological Cancer Drugs Sales by Country (2017-2022)
        7.1.2 Europe Urological Cancer Drugs Revenue by Country (2017-2022)
    7.2 Europe Urological Cancer Drugs Sales by Type
    7.3 Europe Urological Cancer Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Urological Cancer Drugs by Country
        8.1.1 Middle East & Africa Urological Cancer Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Urological Cancer Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Urological Cancer Drugs Sales by Type
    8.3 Middle East & Africa Urological Cancer Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Urological Cancer Drugs
    10.3 Manufacturing Process Analysis of Urological Cancer Drugs
    10.4 Industry Chain Structure of Urological Cancer Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Urological Cancer Drugs Distributors
    11.3 Urological Cancer Drugs Customer
12 World Forecast Review for Urological Cancer Drugs by Geographic Region
    12.1 Global Urological Cancer Drugs Market Size Forecast by Region
        12.1.1 Global Urological Cancer Drugs Forecast by Region (2023-2028)
        12.1.2 Global Urological Cancer Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Urological Cancer Drugs Forecast by Type
    12.7 Global Urological Cancer Drugs Forecast by Application
13 Key Players Analysis
    13.1 Novartis
        13.1.1 Novartis Company Information
        13.1.2 Novartis Urological Cancer Drugs Product Offered
        13.1.3 Novartis Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Novartis Main Business Overview
        13.1.5 Novartis Latest Developments
    13.2 Pfizer
        13.2.1 Pfizer Company Information
        13.2.2 Pfizer Urological Cancer Drugs Product Offered
        13.2.3 Pfizer Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Pfizer Main Business Overview
        13.2.5 Pfizer Latest Developments
    13.3 Johnson & Johnson
        13.3.1 Johnson & Johnson Company Information
        13.3.2 Johnson & Johnson Urological Cancer Drugs Product Offered
        13.3.3 Johnson & Johnson Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Johnson & Johnson Main Business Overview
        13.3.5 Johnson & Johnson Latest Developments
    13.4 AstraZeneca
        13.4.1 AstraZeneca Company Information
        13.4.2 AstraZeneca Urological Cancer Drugs Product Offered
        13.4.3 AstraZeneca Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 AstraZeneca Main Business Overview
        13.4.5 AstraZeneca Latest Developments
    13.5 Astellas
        13.5.1 Astellas Company Information
        13.5.2 Astellas Urological Cancer Drugs Product Offered
        13.5.3 Astellas Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Astellas Main Business Overview
        13.5.5 Astellas Latest Developments
    13.6 Bristol-Myers Squibb
        13.6.1 Bristol-Myers Squibb Company Information
        13.6.2 Bristol-Myers Squibb Urological Cancer Drugs Product Offered
        13.6.3 Bristol-Myers Squibb Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Bristol-Myers Squibb Main Business Overview
        13.6.5 Bristol-Myers Squibb Latest Developments
    13.7 Abbott Laboratories
        13.7.1 Abbott Laboratories Company Information
        13.7.2 Abbott Laboratories Urological Cancer Drugs Product Offered
        13.7.3 Abbott Laboratories Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Abbott Laboratories Main Business Overview
        13.7.5 Abbott Laboratories Latest Developments
    13.8 Celgene Corporation
        13.8.1 Celgene Corporation Company Information
        13.8.2 Celgene Corporation Urological Cancer Drugs Product Offered
        13.8.3 Celgene Corporation Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Celgene Corporation Main Business Overview
        13.8.5 Celgene Corporation Latest Developments
    13.9 Dendreon Corporation
        13.9.1 Dendreon Corporation Company Information
        13.9.2 Dendreon Corporation Urological Cancer Drugs Product Offered
        13.9.3 Dendreon Corporation Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Dendreon Corporation Main Business Overview
        13.9.5 Dendreon Corporation Latest Developments
    13.10 Ferring Pharmaceuticals
        13.10.1 Ferring Pharmaceuticals Company Information
        13.10.2 Ferring Pharmaceuticals Urological Cancer Drugs Product Offered
        13.10.3 Ferring Pharmaceuticals Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Ferring Pharmaceuticals Main Business Overview
        13.10.5 Ferring Pharmaceuticals Latest Developments
    13.11 GlaxoSmithKline
        13.11.1 GlaxoSmithKline Company Information
        13.11.2 GlaxoSmithKline Urological Cancer Drugs Product Offered
        13.11.3 GlaxoSmithKline Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 GlaxoSmithKline Main Business Overview
        13.11.5 GlaxoSmithKline Latest Developments
    13.12 Indevus Pharmaceuticals Inc
        13.12.1 Indevus Pharmaceuticals Inc Company Information
        13.12.2 Indevus Pharmaceuticals Inc Urological Cancer Drugs Product Offered
        13.12.3 Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Indevus Pharmaceuticals Inc Main Business Overview
        13.12.5 Indevus Pharmaceuticals Inc Latest Developments
    13.13 Ipsen
        13.13.1 Ipsen Company Information
        13.13.2 Ipsen Urological Cancer Drugs Product Offered
        13.13.3 Ipsen Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Ipsen Main Business Overview
        13.13.5 Ipsen Latest Developments
    13.14 Roche Healthcare
        13.14.1 Roche Healthcare Company Information
        13.14.2 Roche Healthcare Urological Cancer Drugs Product Offered
        13.14.3 Roche Healthcare Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Roche Healthcare Main Business Overview
        13.14.5 Roche Healthcare Latest Developments
    13.15 Sanofi S.A
        13.15.1 Sanofi S.A Company Information
        13.15.2 Sanofi S.A Urological Cancer Drugs Product Offered
        13.15.3 Sanofi S.A Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Sanofi S.A Main Business Overview
        13.15.5 Sanofi S.A Latest Developments
    13.16 Tolmar Inc
        13.16.1 Tolmar Inc Company Information
        13.16.2 Tolmar Inc Urological Cancer Drugs Product Offered
        13.16.3 Tolmar Inc Urological Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Tolmar Inc Main Business Overview
        13.16.5 Tolmar Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Urological Cancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Urological Cancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Tablets
    Table 4. Major Players of Injection
    Table 5. Global Urological Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 6. Global Urological Cancer Drugs Sales Market Share by Type (2017-2022)
    Table 7. Global Urological Cancer Drugs Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Urological Cancer Drugs Revenue Market Share by Type (2017-2022)
    Table 9. Global Urological Cancer Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 10. Global Urological Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 11. Global Urological Cancer Drugs Sales Market Share by Application (2017-2022)
    Table 12. Global Urological Cancer Drugs Revenue by Application (2017-2022)
    Table 13. Global Urological Cancer Drugs Revenue Market Share by Application (2017-2022)
    Table 14. Global Urological Cancer Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 15. Global Urological Cancer Drugs Sales by Company (2020-2022) & (K Pcs)
    Table 16. Global Urological Cancer Drugs Sales Market Share by Company (2020-2022)
    Table 17. Global Urological Cancer Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Urological Cancer Drugs Revenue Market Share by Company (2020-2022)
    Table 19. Global Urological Cancer Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 20. Key Manufacturers Urological Cancer Drugs Producing Area Distribution and Sales Area
    Table 21. Players Urological Cancer Drugs Products Offered
    Table 22. Urological Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Urological Cancer Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 26. Global Urological Cancer Drugs Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Urological Cancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Urological Cancer Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Urological Cancer Drugs Sales by Country/Region (2017-2022) & (K Pcs)
    Table 30. Global Urological Cancer Drugs Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Urological Cancer Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Urological Cancer Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Urological Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 34. Americas Urological Cancer Drugs Sales Market Share by Country (2017-2022)
    Table 35. Americas Urological Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Urological Cancer Drugs Revenue Market Share by Country (2017-2022)
    Table 37. Americas Urological Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 38. Americas Urological Cancer Drugs Sales Market Share by Type (2017-2022)
    Table 39. Americas Urological Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 40. Americas Urological Cancer Drugs Sales Market Share by Application (2017-2022)
    Table 41. APAC Urological Cancer Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 42. APAC Urological Cancer Drugs Sales Market Share by Region (2017-2022)
    Table 43. APAC Urological Cancer Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Urological Cancer Drugs Revenue Market Share by Region (2017-2022)
    Table 45. APAC Urological Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 46. APAC Urological Cancer Drugs Sales Market Share by Type (2017-2022)
    Table 47. APAC Urological Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 48. APAC Urological Cancer Drugs Sales Market Share by Application (2017-2022)
    Table 49. Europe Urological Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 50. Europe Urological Cancer Drugs Sales Market Share by Country (2017-2022)
    Table 51. Europe Urological Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Urological Cancer Drugs Revenue Market Share by Country (2017-2022)
    Table 53. Europe Urological Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 54. Europe Urological Cancer Drugs Sales Market Share by Type (2017-2022)
    Table 55. Europe Urological Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 56. Europe Urological Cancer Drugs Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Urological Cancer Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 58. Middle East & Africa Urological Cancer Drugs Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Urological Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Urological Cancer Drugs Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Urological Cancer Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 62. Middle East & Africa Urological Cancer Drugs Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Urological Cancer Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 64. Middle East & Africa Urological Cancer Drugs Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Urological Cancer Drugs
    Table 66. Key Market Challenges & Risks of Urological Cancer Drugs
    Table 67. Key Industry Trends of Urological Cancer Drugs
    Table 68. Urological Cancer Drugs Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Urological Cancer Drugs Distributors List
    Table 71. Urological Cancer Drugs Customer List
    Table 72. Global Urological Cancer Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 73. Global Urological Cancer Drugs Sales Market Forecast by Region
    Table 74. Global Urological Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Urological Cancer Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Urological Cancer Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 77. Americas Urological Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Urological Cancer Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 79. APAC Urological Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Urological Cancer Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 81. Europe Urological Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Urological Cancer Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 83. Middle East & Africa Urological Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Urological Cancer Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 85. Global Urological Cancer Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Urological Cancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Urological Cancer Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Urological Cancer Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 89. Global Urological Cancer Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Urological Cancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Urological Cancer Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Novartis Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 93. Novartis Urological Cancer Drugs Product Offered
    Table 94. Novartis Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 95. Novartis Main Business
    Table 96. Novartis Latest Developments
    Table 97. Pfizer Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 98. Pfizer Urological Cancer Drugs Product Offered
    Table 99. Pfizer Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 100. Pfizer Main Business
    Table 101. Pfizer Latest Developments
    Table 102. Johnson & Johnson Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 103. Johnson & Johnson Urological Cancer Drugs Product Offered
    Table 104. Johnson & Johnson Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 105. Johnson & Johnson Main Business
    Table 106. Johnson & Johnson Latest Developments
    Table 107. AstraZeneca Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 108. AstraZeneca Urological Cancer Drugs Product Offered
    Table 109. AstraZeneca Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 110. AstraZeneca Main Business
    Table 111. AstraZeneca Latest Developments
    Table 112. Astellas Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 113. Astellas Urological Cancer Drugs Product Offered
    Table 114. Astellas Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 115. Astellas Main Business
    Table 116. Astellas Latest Developments
    Table 117. Bristol-Myers Squibb Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 118. Bristol-Myers Squibb Urological Cancer Drugs Product Offered
    Table 119. Bristol-Myers Squibb Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 120. Bristol-Myers Squibb Main Business
    Table 121. Bristol-Myers Squibb Latest Developments
    Table 122. Abbott Laboratories Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 123. Abbott Laboratories Urological Cancer Drugs Product Offered
    Table 124. Abbott Laboratories Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 125. Abbott Laboratories Main Business
    Table 126. Abbott Laboratories Latest Developments
    Table 127. Celgene Corporation Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 128. Celgene Corporation Urological Cancer Drugs Product Offered
    Table 129. Celgene Corporation Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 130. Celgene Corporation Main Business
    Table 131. Celgene Corporation Latest Developments
    Table 132. Dendreon Corporation Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 133. Dendreon Corporation Urological Cancer Drugs Product Offered
    Table 134. Dendreon Corporation Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 135. Dendreon Corporation Main Business
    Table 136. Dendreon Corporation Latest Developments
    Table 137. Ferring Pharmaceuticals Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 138. Ferring Pharmaceuticals Urological Cancer Drugs Product Offered
    Table 139. Ferring Pharmaceuticals Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 140. Ferring Pharmaceuticals Main Business
    Table 141. Ferring Pharmaceuticals Latest Developments
    Table 142. GlaxoSmithKline Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 143. GlaxoSmithKline Urological Cancer Drugs Product Offered
    Table 144. GlaxoSmithKline Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 145. GlaxoSmithKline Main Business
    Table 146. GlaxoSmithKline Latest Developments
    Table 147. Indevus Pharmaceuticals Inc Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 148. Indevus Pharmaceuticals Inc Urological Cancer Drugs Product Offered
    Table 149. Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 150. Indevus Pharmaceuticals Inc Main Business
    Table 151. Indevus Pharmaceuticals Inc Latest Developments
    Table 152. Ipsen Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 153. Ipsen Urological Cancer Drugs Product Offered
    Table 154. Ipsen Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 155. Ipsen Main Business
    Table 156. Ipsen Latest Developments
    Table 157. Roche Healthcare Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 158. Roche Healthcare Urological Cancer Drugs Product Offered
    Table 159. Roche Healthcare Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 160. Roche Healthcare Main Business
    Table 161. Roche Healthcare Latest Developments
    Table 162. Sanofi S.A Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 163. Sanofi S.A Urological Cancer Drugs Product Offered
    Table 164. Sanofi S.A Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 165. Sanofi S.A Main Business
    Table 166. Sanofi S.A Latest Developments
    Table 167. Tolmar Inc Basic Information, Urological Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 168. Tolmar Inc Urological Cancer Drugs Product Offered
    Table 169. Tolmar Inc Urological Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 170. Tolmar Inc Main Business
    Table 171. Tolmar Inc Latest Developments
List of Figures
    Figure 1. Picture of Urological Cancer Drugs
    Figure 2. Urological Cancer Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Urological Cancer Drugs Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Urological Cancer Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Urological Cancer Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Tablets
    Figure 10. Product Picture of Injection
    Figure 11. Global Urological Cancer Drugs Sales Market Share by Type in 2021
    Figure 12. Global Urological Cancer Drugs Revenue Market Share by Type (2017-2022)
    Figure 13. Urological Cancer Drugs Consumed in Prostate Cancer
    Figure 14. Global Urological Cancer Drugs Market: Prostate Cancer (2017-2022) & (K Pcs)
    Figure 15. Urological Cancer Drugs Consumed in Bladder Cancer
    Figure 16. Global Urological Cancer Drugs Market: Bladder Cancer (2017-2022) & (K Pcs)
    Figure 17. Urological Cancer Drugs Consumed in Kidney Cancer
    Figure 18. Global Urological Cancer Drugs Market: Kidney Cancer (2017-2022) & (K Pcs)
    Figure 19. Urological Cancer Drugs Consumed in Testicular Cancer
    Figure 20. Global Urological Cancer Drugs Market: Testicular Cancer (2017-2022) & (K Pcs)
    Figure 21. Urological Cancer Drugs Consumed in Others
    Figure 22. Global Urological Cancer Drugs Market: Others (2017-2022) & (K Pcs)
    Figure 23. Global Urological Cancer Drugs Sales Market Share by Application (2017-2022)
    Figure 24. Global Urological Cancer Drugs Revenue Market Share by Application in 2021
    Figure 25. Urological Cancer Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 26. Global Urological Cancer Drugs Revenue Market Share by Company in 2021
    Figure 27. Global Urological Cancer Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 28. Global Urological Cancer Drugs Revenue Market Share by Geographic Region in 2021
    Figure 29. Global Urological Cancer Drugs Sales Market Share by Region (2017-2022)
    Figure 30. Global Urological Cancer Drugs Revenue Market Share by Country/Region in 2021
    Figure 31. Americas Urological Cancer Drugs Sales 2017-2022 (K Pcs)
    Figure 32. Americas Urological Cancer Drugs Revenue 2017-2022 ($ Millions)
    Figure 33. APAC Urological Cancer Drugs Sales 2017-2022 (K Pcs)
    Figure 34. APAC Urological Cancer Drugs Revenue 2017-2022 ($ Millions)
    Figure 35. Europe Urological Cancer Drugs Sales 2017-2022 (K Pcs)
    Figure 36. Europe Urological Cancer Drugs Revenue 2017-2022 ($ Millions)
    Figure 37. Middle East & Africa Urological Cancer Drugs Sales 2017-2022 (K Pcs)
    Figure 38. Middle East & Africa Urological Cancer Drugs Revenue 2017-2022 ($ Millions)
    Figure 39. Americas Urological Cancer Drugs Sales Market Share by Country in 2021
    Figure 40. Americas Urological Cancer Drugs Revenue Market Share by Country in 2021
    Figure 41. United States Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Canada Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Mexico Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Brazil Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. APAC Urological Cancer Drugs Sales Market Share by Region in 2021
    Figure 46. APAC Urological Cancer Drugs Revenue Market Share by Regions in 2021
    Figure 47. China Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Japan Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 49. South Korea Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Southeast Asia Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 51. India Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Australia Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Europe Urological Cancer Drugs Sales Market Share by Country in 2021
    Figure 54. Europe Urological Cancer Drugs Revenue Market Share by Country in 2021
    Figure 55. Germany Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 56. France Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 57. UK Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Italy Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Russia Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Middle East & Africa Urological Cancer Drugs Sales Market Share by Country in 2021
    Figure 61. Middle East & Africa Urological Cancer Drugs Revenue Market Share by Country in 2021
    Figure 62. Egypt Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 63. South Africa Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Israel Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Turkey Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 66. GCC Country Urological Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Manufacturing Cost Structure Analysis of Urological Cancer Drugs in 2021
    Figure 68. Manufacturing Process Analysis of Urological Cancer Drugs
    Figure 69. Industry Chain Structure of Urological Cancer Drugs
    Figure 70. Channels of Distribution
    Figure 71. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Urological Cancer Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Urological Cancer Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Urological Cancer Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports